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Purpose: This study assessed whether multisegmental disease that is severe nough to 
require an inflow procedure adversely affects infrainguinal bypass patency, limb salvage, 
or patient survival rates. 
Methods: The records of 495 patients who underwent 551 infrainguinal bypass grafting 
procedures were reviewed. Saphenous vein and prosthetic grafts were evaluated sepa- 
rately. Graft patency rates, patient limb salvage rates, and patient survival rates in those 
grafts that arose from a reconstructed inflow source were compared with those that arose 
from normal, nonreconstructed inflow sources. When grafts had either hemodynamic 
failure or occlusion, the cause of failure was identified. 
Results: Four-year primary patency rates in vein grafts that arose from a reconstructed 
inflow sources were lower than those in grafts that arose from nonreconstructed inflow 
sources (41% vs 54%; p = 0.006). Assisted primary patency rates and secondary patency 
rates, however, were similar (62% vs 74% and 64% vs 77%, respectively). The 4-year 
primary patency rate (45% vs 55%), assisted primary patency rate (60% vs 60%), and 
secondary patency rate (60% vs 61%) in prosthetic grafts did not vary based on inflow 
source. The most common cause of graft failure was inflow failure, except in the vein 
grafts that did not require an inflow procedure, in which the most common cause of 
failure was graft failure. Inflow failure occurred in 24% and 22% of the vein and 
prosthetic grafts with multisegmental disease, respectively, bu~ in only 7% (p < 0.001) 
and 10% (p < 0.05), respectively, of those that arose from normal nonreconstructed 
inflow. The presence of an inflow procedure did not affect limb salvage rates or patient 
survival rates, regardless of graft material. 
Conclusions: Long-term patency rates, patient limb salvage rates, and survival rates in 
patients with a reconstructed inflow source were similar to those of patients with a 
normal nonreconstructed inflow. A major cause of occlusion is inflow failure, and this 
occurs in a greater proportion of patients with multisegmental disease. These patients, in 
particular, may benefit from patient surveillance to screen for progression of their inflow 
disease and to allow for intervention before infrainguinal graft occlusion. (J Vase Surg 
1997;26:928-38.) 
Patients who have normal aortoiliac systems and 
those who have varying degrees of inflow occlusive 
disease may require infrainguinal reconstruction. 
These infrainguinal arterial revascularizations may 
therefore originate from a normal inflow source or 
from an inflow source that was reconstructed either 
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before or concurrent with the infrainguinal bypass 
graft. Although infrainguinal bypass patency rates 
from reconstructed inflow sources have been report- 
ed, 1-7 there are few data to suggest whether a recon- 
structed inflow source functions as well as a normal 
nonreconstructed inflow source with regard to in- 
ffainguinal bypass patency rates. In addition, the ef- 
fect o f  inflow reconstruction on infrainguinal bypass 
grafts with different materials is not clear. 1,3 Finally, 
because patients who have multisegmental disease 
have a greater incidence of disease progression, 8 it is 
not known whether, after correction of the inflow 
lesion, this progression will adversely affect infrain- 
guinal bypass results. I f  it does affect results, how 
should these patients be managed? 
The purpose of this study was to investigate 
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whether multisegmental disease that is severe 
enough to require an inflow procedure adversely 
affects infrainguinal graft patency, patient limb sal- 
vage, or patient survival rates compared with those of 
patients who have only infrainguinal disease at the 
time of revascularization. 
METHODS 
The records of 495 patients who underwent pri- 
mary infrainguinal revascularization procedures for 
arterial occlusive disease bctween 1990 and 1995 
were reviewed. Preoperative risk factors, indications 
for operation, graft material, and the sites of the 
distal anastomosis were noted. The patients were 
divided into two groups. The "Inflow" group con- 
sisted of those patients who had reconstructed inflow 
before, or concurrent with, the primary infrainguinal 
revascularization procedure, whereas the "No in- 
flow" group had normal nonreconstructed inflow. 
Saphenous vein and prosthetic bypass grafts were 
evaluated separately. 
Inflow procedures were categorized as aortoil- 
iofemoral bypass procedures, extraanatomic bypass 
procedures (femorofemoral and axillofemoral bypass 
procedures), balloon angioplasty with and without 
stent placement, and iliofemoral endarterectomy. 
The iliofemoral endarterectomy procedures per- 
formed were extensive ndarterectomy procedures 
that required mobilization of the inguinal igament 
and proximal clamping at the level of the common 
iliac artery. These procedures were performed when 
necessary to provide satisfactory inflow to the infrain- 
guinal bypass graft that was required to treat the 
patient's condition. When the need for an inflow 
procedure was questioned after review of the angio- 
gram, intraarterial pressure measurements were ob- 
tained cither in the angiography suitc or operating 
room. Systolic pressure gradients of at least 5 mm Hg 
across lesions, or mean pressure gradients of at least 
10 mm Hg after papaverine administration, were 
considered significant. Attempts were made to place 
the proximal anastomosis of the infrainguinal bypass 
graft on autogcnous tissue. 
Changes in anlde-brachial indexes, duplex ultra- 
sound scans, and arteriograms were used after the 
operation to assess bypass graft patency. Grafts were 
considered patent if they met the criteria established 
by the Society for Vascular Surgery. 9 Saphenous vein 
grafts were surveyed with ankle-brachial indexes and 
duplex scans routinely at months 3, 6, and 12 and 
then yearly thereafter. Impending venous graft fail- 
ure was indicated by recurrent clinical symptoms, 
changes in the ankle-brachial index of 0.15 below the 
postoperative index, and peal; systolic velocities of 
less than 40 cm/sec or greater than 150 cm/sec by 
duplex scan. Patients who had prosthetic bypass 
grafts were examined yearly. Noninvasive tests were 
performed sporadically on the basis of recurrent clin- 
ical symptoms or dj'minished pulses on physical ex- 
amination. 
Operative results were assessed using conven- 
tional ife table analysis. Primary patency was defined 
as the length of time the graft remained patent with- 
out any intervention whatsoever. Assisted primary 
patency was defined as the length of time a graft 
remained patent allowing for interventions to rescue 
a failing but patent graft. Secondary patency was 
defined as the length of time the graft remained 
patent allowing for interventions to restore throm- 
hosed grafts. For graft patency, the reporting interval 
of those individuals who died or were lost to fol- 
low-up stopped at the time their graft was last noted 
to be patent. Each cndpoint was tal;en as the middle 
of the period between which the graft was last docu- 
mented open and when it was revised or clearly 
shown to be occluded. Hemodynamic failure did not 
end assisted primary patency or secondary patency as 
long as the graft itself was open at exploration. 
Graft failure was defined as an event hat ended 
either primary patency, assisted primary patency, or 
secondary patcncy. Causes of graft failure were 
grouped into five categories: inflow failure, outflow 
failure, graft failure, nonmechanical f ilure, and un- 
known. Inflow failure was defined as either failure of 
an inflow procedure or the development of a new 
inflow lesion. Outflow failure was defined as the 
development ofa new outflow lesion that resulted in 
insufficient runoff. Graft failure was defined as steno- 
ses at the proximal or distal anastomosis or in the 
body of the graft. Also included in this group was the 
development of arteriovenous fistulas. A label of 
nonmechanical f ilure was applied when a graft had 
failed, but the failure could not be attributed to an 
inflow, outflow, or graft lesion. In cases in which the 
cause of failure was unknown because no interven- 
tion was made on the graft, it was labeled as such. 
All data were stored and analyzed on a Macintosh 
7100/66AV computer (Apple Computer, Cuper- 
tino, Calif.). Statistical analysis was performed using 
StatView 4.02 (Abacus Concepts, Berkeley, Calif.). 
Life table estimates were compared using the log- 
rank test. Data were also analyzed using a propor- 
tional hazards regression model. Standard error esti- 
mates performed by StatView 4.02 were by the 
method of Greenwood, and the authors calculated 
the standard error by the method ofPeto. Analysis of 
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Table I. Group characteristics 
Vent + Inflow Vein Prosthetic +Inflow Prosthetic 
Number 70 (21%) 269 (79%) 88 (42%) 124 (58%) 
Age(yr±SEM) 68 ± 1 68 ± 1 69-+ 1 70-+ 1 
Men 39 (56%) 159 (59%) 58 (66%) 57 (46%) 
Risk Factors 
IDDM 16 (23%) 90 (33%) 16 (18%) 23 (19%) 
Smoker 31 (44%) 80 (30%) p = 0.02 51 (58%) 49 (40%) 
CAD 37 (53%) 131 (49%) 52 (59%) 69 (56%) 
Hypertension 46 (66%) 184 (68%) 62 (70%) 84 (68%) 
CVD 15 (21%) 49 (23%) 28 (32%) 30 (24%) 
Renal 20 (29%) 58 (22%) 17 (19%) 21 (17%) 
COPD 5 (7%) 16 (10%) 15 (17%) 6 (5%) 
Hyperlipid 7 (10%) 27 (10%) 20 (23%) 14 (11%) 
Indication 
Salvage 46 (66%) 208 (77%) p = 0.05 49 (56%) 64 (52%) 
Distal anastomosis 
AKI'op 8 (11%) 51 (19%) 77 (87%) 111 (90%) 
BKPop 27 (39%) 88 (33%) 11 (13%) 13 (10%) 
Tibial artery 35 (50%) 130 (48%) -- -- 
p = 0.002 
z0 = 0.01 
p = 0.003 
p = 0.03 
SEM, standard error of the mean; IDDM, insulin-dependent diabetes mellitus; CAD, coronary artery disease; CVD, cerebrovascular 
disease; COPD, chronic obstructive pulmonary disease; AKPop, above-knee popliteal artery; BKPop, below-knee popliteal artery. 
variance and ×2 analysis, as appropriate, were used to 
assess differences between continuous and nominal 
variables. A p value less than 0.05 was considered to 
indicate a statistically significant difference. 
RESULTS 
A total of 551 primary infrainguinal revascular- 
ization procedures were reviewed. Adjunctive inflow 
procedures were performed in 70 of the 339 (21%) 
with saphenous vein grafts. These operations were 
performed either before (n = 27) or concurrent with 
(n = 43) the saphenous vein graft infrainguinal by- 
pass procedure (Vein+Inflow; Table I). No inflow 
procedure was required in the remaining 269 grafts 
(79%; Vein). The Vein+Inflow and Vein populations 
were similar with regard to age (68 + I years vs 68 + 
1 years), number of in situ grafts (23% vs 26%), and 
sites of distal anastomoses (above-knee popliteal, 
11% vs 19%; below-knee popliteal, 39% vs 33%; tibial, 
50% vs 48%). Significant population differences were 
more current smokers (44% vs 30%; p = 0.02) and 
fewer operations for limb salvage (44% vs 77%; p = 
0.05) in the Vein+Inflow group. 
There were 212 prosthetic bypass grafts, of which 
88 (42%) had a prior (n = 17) or concurrent (n = 
71) inflow procedure (Prosthetic+Inflow), whereas 
124 (58%) did not (Prosthetic). The Prosthet- 
ic+Inflow and Prosthetic populations were similar 
with regard to age (69 + 1 years vs 70 + 1 years), 
operations for limb salvage (56% vs 52%), and sites of  
distal anastomoses (above-knee popliteal, 88% vs 
90%). Significant population differences were more 
men (66% vs 46%; p = 0.004), more current smokers 
(58% vs 40%; p = 0.01), more patients with pulmo- 
nary disease (17% vs 5%; p = 0.003), and more 
patients with hyperlipidemia (23% vs 11%; p = 0.03) 
in the Prosthetic+Inflow group. 
Inflow procedures included 71 aortoiliofemoral 
bypass procedures (45%), 56 iliofemoral endarterec- 
tomy procedures (35%), 23 balloon angioplasty pro- 
cedures (15%), and eight extraauatomic bypass pro- 
cedures (5%). Forty-four inflow procedures (28%) 
were performed before, and 114 (72%) concurrent 
with, the infrainguinal bypass procedures. More aor- 
toiliofemoral bypass procedures (p < 0.01) were per- 
formed before, whereas more iliofemoral endarterec- 
tomy procedures (p < 0.01) were performed con- 
current with the infrainguinal bypass procedure. The 
type of the inflow procedures did not vary between 
the Vein+Inflow and Prosthetic+Inflow groups, but 
the Prosthetic +Inflow group had more inflow proce- 
dures performed concurrently than the Vein+Inflow 
group (61% vs 80%; p = 0.001). 
The 4-year primary patency rates for saphenous 
vein iufrainguinal revascularization procedures were 
lower in Vein+Inflow group (41% vs 54%; p = 
0.006) when compared with the vein grafts from 
normal inflow sources (Fig. 1). There were no differ- 
ences in the assisted primary patency and secondary 
patency rates in vein grafts that arose from a recon- 
structed inflow source compared with those that 
arose from a nonreconstructed inflow source. The 
assisted primary patency rates and secondary patency 
rates in the Vein+Inflow and Vein groups at 4 years 
were similar (62% vs 74% [Table II] and 64% vs 77% 
[Table III], respectively). In patients who had pros- 
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Fig. 1. Cumulative survival curve for primary patency rates (PP) and assisted primary patency 
rates (APP) for saphenous vein bypass grafts that arose from reconstructed inflow sources 
(circles) and normal nonreconstructed inflow sources (squares). Dashed line represents where 
the standard error of  the mean is 10% or greater. 
Tab le  I I .  Life table o f  cumulat ive pr imary patency data for inf low and no  inf low groups wi th  
saphenous  vein bypass grafts 
No. of grafts lost because of 
Time No. of grafts No. of failed Lost to Interval patency Cumulative 
(mo) at risk grafts Duration Death follow-up rate patency rate (%) 
Standard error (%) 
Greenwood Peto 
Vein + Inflow 
0-1 70 11 1 0 13 0.825 100.0 0.0 0.0 
1-6 45 8 0 0 11 0.797 82.5 4.8 5.1 
6-12 26 6 0 0 0 0.769 65.8 6.5 7.5 
12-18 20 1 3 0 0 0.946 50.6 7.4 8.0 
18-24 16 1 2 0 0 0.933 47.9 7.5 8.6 
24-30 13 1 1 0 2 0.913 44.7 7.6 9.2 
30-36 9 0 3 0 0 1.000 40.8 7.9 10.5 
36-42 6 0 1 0 0 1.000 40.8 7.9 12.8 
42-48 5 1 1 0 0 0.778 40.8 7.9 14.0 
48-54 3 1 1 0 0 0.600 31.7 10.1 15.1 
54-60 1 0 1 0 0 1.000 19.0 11.15 17.1 
Vein 
0-1 269 18 10 16 32 0.925 100.0 0.0 0.0 
1-6 193 22 7 8 22 0.874 92.5 1.7 1.8 
6-12 134 16 6 4 9 0.871 80.8 2.8 3.1 
12-18 99 7 10 4 6 0.921 70.4 3.4 3.8 
18-24 72 4 7 2 6 0.938 64.9 3.7 4.5 
24-30 53 2 4 1 2 0.960 60.9 4.0 5.2 
30-36 44 3 5 0 1 0.927 58.4 4.2 5.7 
36-42 35 0 4 0 2 1.000 54.1 4.6 6.2 
42-48 29 2 6 0 0 0.923 54.1 4.6 6.8 
48-54 21 1 5 0 0 0.946 50.0 5.1 7.7 
54-60 15 0 9 1 5 1.000 47.3 5.5 8.9 
thet ic  infrainguinal  grafts, there were no  differences 
at 4 years for pr imary patency rate (45% vs 55%; 
Tab le  IV),  assisted pr imary patency rate (60% vs 60%; 
Tab le  V),  or  secondary patency rate (60 vs 61%) 
regardless o f  the inf low source (Fig. 2). Patency rates 
were not  affected by the site o f  distal anastomosis ,  the 
indicat ion for surgery, the inf low procedure  per- 
fo rmed,  nor  the t iming  o f  the inf low procedure.  In  
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Table I l L  Life table o f  cumulative assisted primary patency data for inflow and no inflow groups 
with saphenous vein bypass grafts 
No. of grafts lost because of 
Time No. of grafts No. of failed Lost to Interval patency Cumulative 
(mo) at risk grafts Duration Death follow-up rate (%) patency rate (%) 
Standard error 
(%) 
Greenwood Peto 
Vein + Inflow 
0-1 70 8 1 0 13 0.873 
1-6 48 4 0 0 11 0.906 
6-12 33 4 1 0 1 0.875 
12-18 27 1 5 0 0 0.959 
18-24 21 0 3 0 1 1.00 
24-30 17 1 1 0 2 0.935 
30-36 13 0 4 0 0 1.000 
36-42 9 0 2 0 0 1.000 
42-48 7 0 2 0 0 1.000 
48-54 5 0 1 0 0 1.000 
54-60 4 0 2 0 2 1.000 
Vein 
0-1 269 15 10 16 33 0.937 
1-6 195 11 7 8 22 0.938 
6-12 147 9 12 4 8 0.933 
12-18 114 3 15 4 7 0.970 
18-24 85 2 10 5 6 0.973 
24-30 62 1 7 2 2 0.982 
30-36 50 0 6 0 1 1.000 
36-42 43 1 5 0 3 0.974 
42-48 34 1 7 1 0 0.967 
48-54 25 1 5 0 0 0.956 
54-60 19 0 13 1 5 1.000 
100.0 0.0 0.0 
87.3 4.2 4.5 
79.1 5.5 6.3 
69.2 6.6 7.4 
66.4 6.9 8.4 
66.4 6.9 9.3 
62.1 7.7 10.6 
62.1 7.7 12.7 
62.1 7.7 14.4 
62.1 7.7 17.1 
62.1 7.7 19.1 
100.00 0.0 0.0 
93.7 1.6 1.7 
87.9 2.3 2.5 
82.0 2.8 3.3 
79.6 3.1 3.9 
77.5 3.3 4.7 
76.1 3.6 5.3 
76.1 3.6 5.7 
74.1 4.0 6.5 
71.7 4.5 7.6 
68.5 5.3 8.8 
bypass procedures performed with saphenous vein 
grafts, smoking did not  affect patency rates. In those 
bypass procedures with a prosthetic graft, secondary 
patency rates were lower in smokers (40% vs 60%; 
p < 0.01) regardless o f  the inflow status. Patency 
rates did not  differ significantly when stratified by the 
various inflow procedures performed, nor by the 
timing of  the inflow procedure. When these stratifi- 
cations were pcrformcd, howcvcr, thcrc wcrc not 
enough members in each group to allow for accurate 
statistical analysis. 
The most common cause of  infrainguinal graft 
failure in the Vein+Inf low group was inflow failure, 
which caused 17 of  the 36 bypass failures (47%). 
Inflow failure was responsible for only 20 of  the 83 
infrainguinal bypass failures in the Vein group (24%; 
p < 0.05). The most common cause of  failure in the 
Vein group, however, was graft failure, which was 
responsible for 27 of  the 83 bypass failures (32%; 
Table VI). The most common cause o f  failure in 
patients who had a prosthetic graft was inflow failure, 
regardless o f  whether a reconstructed inflow was 
needed. Inflow failurc was rcsponsiblc for 19 o f  the 
41 infrainguinal bypass failures in the Prosthet- 
ic+Inf low group (46%) and 13 of  the 38 bypass 
failures in thc Prosthetic group (34%; Table VII) .  
Complete inflow occlusion with continued infrain- 
guinal bypass graft patency (pseudoocclusion) oc- 
curred in one patient in the Vein+Inf low group and 
in two patients in the Vein group. This phenomenon 
did not occur in the patients who had prosthetic 
infrainguinal bypass grafts. 
Inflow failure occurred at a greater frequency in 
those infrainguinal bypass grafts that arose from a 
reconstructed inflow source regardless o f  graft type. 
In  the Vein+Inf low group, 17 of  the 70 bypass grafts 
had an inflow failure (24%), whereas in the Vein 
group only 20 of  the 269 bypass grafts had an inflow 
failure (7%; p < 0.001). The frequency of  graft fail- 
ure, outflow failure, and nonmechanical failure were 
similar between the Vein+Inf low group and the 
Vein group. In the Prosthetic+Inf low group, I9  o f  
the 88 bypass grafts had an inflow failure (22%), 
whereas in the Prosthetic group only 13 of  the 124 
bypass grafts failed as a result o f  inflow failure (10%; 
p < 0.05). The frequency of  graft failure, outflow 
failure, and nonmechanical failure were similar in the 
Prosthetic+Inf low group compared with the Pros- 
thetic group. 
More impending graft failures were identified in 
patients who had saphenous vein grafts than in those 
with prosthetic grafts. O f  the 1 i9  saphenous vein 
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Table IV. Life table of cumulative primary patency data for inflow and no inflow groups with 
prosthetic bypass grafts 
Time No. of grafts No. of failed 
(mo) at risk grafts 
No. of grafts lost because of Standard error (%) 
Lost to Interval patency Cumulative 
Duration Death follow-up rate patency rate (%) Greenwood Peto 
Prosthetic +Inflow 
0-1 88 8 1 4 
1-6 63 7 0 2 
6~12 48 8 1 1 
12-18 35 4 0 3 
18-24 25 2 2 1 
24-30 17 1 0 0 
30:36 14 1 1 0 
36-42 12 0 1 1 
42-48 10 1 0 0 
48-54 9 1 3 0 
54-60 5 0 4 0 
Prosthetic 
0-1 124 7 3 10 
1-6 96 9 2 2 
6-12 76 7 6 3 
12-18 55 5 4 3 
18-24 42 4 4 0 
24-30 28 3 0 0 
30-36 25 0 4 1 
36-42 19 0 1 0 
42-48 18 2 6 1 
48-54 9 0 4 0 
54-60 4 0 4 0 
12 0.899 100.0 0.0 0.0 
6 0.881 89.9 3.4 3.6 
3 0.824 79.3 4.8 5.2 
3 0.875 65.3 6.0 6.5 
3 0.909 57.2 6.5 7.5 
2 0.938 52.0 6.9 8.7 
0 0.926 48.7 7.2 9.3 
0 1.000 45.1 7.5 9.6 
0 0.900 45.1 7.5 10.6 
0 0.867 40.6 8.0 10.4 
1 1.000 35.2 8.6 12.7 
8 0.938 100 0.0 0.0 
7 0.901 93.8 2.3 2_5 
5 0.899 84.5 3.6 4.0 
1 0.902 75.9 4.5 5.0 
6 0.892 68.5 5.1 5_9 
0 0.893 61.1 5.7 7.0 
1 1.000 54.5 6.2 7.3 
0 1.000 54.5 6.2 8.3 
0 0.862 54.5 6.2 8.6 
1 1.000 47.0 7.3 11.2 
0 1.000 47.0 7.3 16.9 
grafts that failed, 52 (44%) were identified before 
graft occlusion, whereas only 13 of the 79 failed 
prosthetic grafts (17%) were identified before graft 
occlusion. The revisions performed in hemodynami- 
cally compromised saphenous vein grafts to establish 
assisted primary patency were 17 inflow procedures, 
18 patch angioplasty procedures at the proximal 
anastomosis, seven patch angioplasty procedures 
within the body of the graft, three arteriovenous 
fistula ligations, two patch angioplasty procedures at 
the distal anastomosis, and five outflow procedures. 
The revisions of the 13 prosthetic grafts included six 
inflow procedures, four patch angioplasty procedures 
at the proximal anastomosis, two patch angioplasty 
procedures at the distal anastomosis, and one out- 
flow procedure. 
Limb salvage and patient survival rates were unaf- 
fected by inflow status. Limb salvage rates for the 
Vein+Inflow and Vein groups at 4 years were 87% 
and 81%, respectively, and 4-year survival rates were 
72% and 65%, respectively. Five-year limb salvage 
rates for Prosthetic+Inflow and Prosthetic grafts 
were 88% and 85%, respectively, and 5-year survival 
rates were 54% and 65%, respectively. The limb sal- 
vage rate was lower at 5 years in those patients whose 
vein grafts were operated on for salvage (75% vs 97%; 
p < 0.001) and in those with a tibial anastomosis 
(above-knee popliteal, 86%; below-knee popliteal, 
86%; tibial, 79%; p = 0.04). The patient survival rate 
mirrored the limb salvage rate, and at 5 years it was 
lower in those patients who underwent operation for 
limb salvage (33% vs 89%; p < 0.0001) and in those 
patients with a more distal anastomosis (above-knee 
popliteal, 80%; below-knee popliteal, 57%; tibial, 
35%; p < 0.002). In patients with prosthetic grafts, 
the limb salvage rate was lower at 5 years in those 
patients who underwent operation for salvage (75% 
vs 96; p < 0.001), as was the patient survival rate 
(42% vs 78%; p = 0.0001). In prosthetic grafts, limb 
salvage and patient survival rates were independent 
of the site of  the distal anastomosis. 
DISCUSSION 
Patients who need infrainguinal bypass proce- 
dures often require both an inflow procedure and an 
infrainguinal bypass graft to adequately treat the 
ischemic symptoms. We attempted to assess whether 
those infrainguinal bypass grafts hat arose from a 
reconstructed inflow source performed as well as 
those that arose from normal nonreconstructed in- 
flow. Eidt and Charlesworth s reported 4-year in- 
frainguinal patency rates of  80%, whereas Taylor et 
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Fig. 2. Cumulative survival curve for primary patency rates (PP) and assisted primary patency 
rates (APP) for prosthetic vein bypass grafts that arose from reconstructed inflow sources 
(circles) and normal nonreconstructed inflow sources (squares). 
Tab le  V.  Life table o f  cumulat ive assisted pr imary patency data for inf low and no  inf low groups wi th  
prosthet ic  bypass grafts 
No. of grafts lost because of Standard error (%) 
Time No. of grafts No. of failed Lost to Interval patency Cumulative 
(mo) at risk grafts Duration Death follow-up rate patency rate (%) Greenwood Peto 
0-1 88 7 1 4 12 0.912 100.0 0.0 0.0 
1-6 64 6 0 3 6 0.899 91.2 3.2 3.4 
6-12 49 6 2 1 3 0.870 82.0 4.6 5.0 
12-18 37 4 0 3 3 0.882 71.3 5.7 6.3 
18-24 27 1 3 1 3 0.957 62.9 6.4 7.4 
24-30 19 0 1 0 2 1.000 60.2 6.6 8.7 
30-36 16 0 2 0 0 1.000 60.2 6.6 9.5 
36-42 14 0 2 1 0 1.000 60.2 6.6 10.2 
42-48 11 1 0 0 0 0.909 60.2 6.6 11.5 
48-54 10 2 3 0 0 0.765 54.8 8.0 11.6 
54-60 5 0 4 0 1 1.000 41.9 10.0 14.3 
Prosthetic 
0-1 124 6 3 10 8 0.947 100.0 0.0 0.0 
1-6 97 9 2 2 7 0.902 94.7 2.1 2.5 
6-12 77 5 5 3 6 0.929 85.4 3.5 3.9 
12-18 58 4 4 3 2 0.925 79.3 4.2 4.8 
18-24 45 4 4 0 6 0.900 73.4 4.8 5.6 
24-30 31 3 1 0 0 0.902 66.0 5.6 6.8 
30-36 27 0 5 1 1 1.000 59.5 6.1 7.2 
36-42 20 0 1 0 0 1.000 59.5 6.1 8.4 
42-48 19 2 7 1 0 0.867 59.5 6.1 8.6 
48-54 9 0 4 0 1 1.000 51.6 7.5 11.8 
54-60 4 0 4 0 0 1.000 51.6 7.4 17.7 
al. 6 had better  results, w i th  6-year patency rates o f  
87%, a l though their  on ly  inf low in tervent ion  was an 
i l iofemoral  endarterectomy.  Our  patency rates for 
saphenous vein grafts combined  wi th  an inf low pro-  
cedure were similar to these. Actuarial  survival analy- 
sis o f  our  data revealed long- te rm patency rates, l imb 
salvage rates, and pat ient  survival rates were all unaf- 
fected by the need  for an inf low procedure ,  prov id ing  
that  those pat ients wi th  impend ing  graft failure were 
ident i f ied and the graft cor rected before thrombosis .  
The  on ly  difference ident i f ied wi th in  our  groups 
was that  the pr imary patency rate was lower  in the 
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Table VI. Causes of graft failure in saphenous vein bypass grafts 
Causes of failure No. 
Vein + Inflow (n = 70) 
Frequency 
Vein (n = 269) 
No. Frequency 
Inflow 17 (47%) 
Outflow 4 (11%) 
Graft 6 (17%) 
Nonmechanical 0 (0%) 
Unknown 9 (25%) 
Total 36 
0.24 
0.06 
0.09 
0.00 
20 (24%) 
(p < 0.05) 
14 (17%) 
27 (32%) 
1 (1%) 
21 (25%) 
83 
0.07 
p < 0.001) 
0.05 
0.10 
<0.01 
Table VII.  Causes of graft failure prosthetic bypass grafts 
Prosthetic + Inflow (n -  88) 
Causes or failure No. Frequency 
Prosthetic (n = 124) 
No. Frequency 
Inflow 19 (46%) 0.22 
Outflow 8 (20%) 0.09 
Graft 5 (12%) 0.06 
Nonmcchanical 1 (2%) <0.01 
Unknown 8 (20%) 
Total 41 
13 (34%) 
7 (18%) 
3 (8%) 
2 (5%) 
13 (34%) 
38 
0.10 
(.0 < 0.05) 
0.06 
0.02 
0.02 
Vein+Inflow group compared with the Vein group. 
This difference resolved with assisted primary pa- 
tency. We attempted to explain this difference by 
examining the causes of failure within each group. In 
saphenous vein bypass grafts, more failures in those 
infrainguinal bypass grafts that arose from a recon- 
structed inflow source were caused by inflow failure 
than in those that arose from normal nonrecon- 
structed inflow source. Inflow failure in the latter 
group, however, did represent the second-leading 
cause of failure. This difference was not apparent in 
the prosthetic bypass grafts, as the leading cause of 
failure in both of these groups was inflow failure. 
Inflow failure occurred at a greater frequency in 
those patients whose bypass graft arose from a recon- 
structed inflow source compared with those whose 
bypass graft arose from a nonreconstructed inflow 
source. 
Inflow failure as a major cause of infrainguinal 
bypass failure is not a new idea. Several studies have 
reported progression of aortoiliac discasc in 13% to 
42% of patients with inflow disease, s l° The rate of 
disease progression appcars to be different between 
those who have multiscgmental discasc compared 
with those with unilcvcl discase and may suggest that 
there is a biologic difference between these two 
groups, n Ellenby et al.4 demonstrated that 50% of 
the failurcs in a study of sequential femorofemoropop- 
liteal bypass were a result of progression of  inflow 
disease. This experience is not limited to those pa- 
tients who have multisegmental disease. Charles- 
worth et al. 12 showed that patients who had no 
evidence of aortoiliac insufficiency by clinical exami- 
nation and angiographic evaluation, but who had a 
decreased pulsatility index at the femoral artery, had 
lower patency rates in their femoropopliteal grafts 
than patients who had a normal pulsatility index. 
Ouriel et al.,13 however, found that after thromboly- 
sis most graft thromboses were caused by graft fail- 
ures (proximal and distal anastomosis and graft 
body) and that only 4% to 7% ofinfrainguinal bypass 
failures were caused by inflow failure. This difference 
may be explained by the fact that the group of pa- 
tients who underwent successful thrombolysis repre- 
sents a subpopulation ofpatients encompassed in our 
larger group. Few patients in this current series un- 
derwent successful thrombolysis. This is demon- 
strated through the fact that the assisted primary 
patency rates and secondary patency rates were not 
different. Because of this small number of patients 
who underwent successful thrombolysis, analysis of 
the causes of failure in this subpopulation is not 
possible. In this report, inflow failure appears to play 
a major role in inftainguinal bypass graft failure. 
These failures are more readily identified before graft 
occlusion in the saphenous vein bypass group be- 
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cause those patients undergo intense graft surveil- 
lance, which will herald impending graft failure and 
further investigation to identify its source. This is not 
so in the prosthetic grafts, in which most inflow 
failures are identified after graft occlusion. Because 
inflow failure is a major cause ofinfrainguinal bypass 
occlusion, an argument can be made for intense 
patient surveillance to detect these inflow lesions 
before graft occlusion. This may be particularly im- 
portant in patients who have multisegmental disease 
because they may have a more accelerated progres- 
sion of  their disease. Although the calculation of  the 
true incidence of  progression of  inflow disease is not 
possible in these groups as a result o f  statistical limi- 
tations, there is a greater proport ion of  patients with 
multisegmental disease in whom progression of  this 
disease develops and leads to infrainguinal graft fail- 
ure. 
Unlike saphenous vein grafts, routine monitor ing 
with anlde-brachial indexes and duplex ultrasound is 
not  currently accepted as effective in the surveillance 
of  prosthetic bypass grafts. Assessing and monitor ing 
patients for inflow disease is also a difficult task; 
however, duplex ultrasound is showing promise in 
evaluating aortoiliac stenosis. Recent reports have 
described sensitivities between 81% and 100% and 
specificities between 58% and 95% in detecting aor- 
toiliac disease, depending on the degree o f  steno- 
sis? 4-17 For patients who have multisegmental dis- 
ease, surveillance through history, physical exam- 
ination, and segmental pressures augmented with 
duplex ultrasound may be indicated to detect pro- 
gression of  inflow disease. Correction o f  this progres- 
sion may prevent infrainguinal graft failure. Patients 
who have prosthetic infrainguinal bypass grafts and 
multisegmental disease may benefit most from this 
approach because they do not currently receive rou- 
tine graft surveillance that would identify impending 
graft failure. 
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DISCUSSION 
Dr. Frank J. Veith (Bronx, N.Y.). This is an interest- 
ing, well-written, and well-presented paper. It is important 
for several reasons. 
First, it challenges the generally accepted notion that 
almost all infrainguinal graft failures are caused by anasto- 
motic intimal hyperplasia or vein graft stenoses. We noted 
the importance of inflow problems when Dr. Luis Sanchez 
presented various aspects of our work on failing inftaingui- 
nal polytetrafluoroethylene (PTFE) and vein grafts to this 
Society in 1991 and 1993 (J Vasc Surg 1991;14:729-38 
and 1993;18:981-90). In these articles, we observed that 
inflow and outflow lesions were more important causes of 
failure with both vein and prosthetic grafts than most 
people realized. Today's paper by Dr. Eagleton and his 
colleagues certainly supports our now-old but unrecog- 
nized observations about the importance of inflow disease 
as a cause of failure of both vein and PTFE grafts. Their 
work also supports our 1993 recommendation that surveil- 
lance is indeed justified with PTFE infrainguinal bypass 
grafts just as it is with vein bypass grafts. 
I have some other comments and related questions. 
Although the authors used preoperative and intraoperative 
pressure measurements with papaverine to detect inflow 
stenoses, they may have still missed some. As we showed in 
1990 (J Vase Surg 1990;12:78-83), some inflow stenoses 
that are quite significant hemodynamically can be missed 
unless femoral pressure measurements are made after flow 
is established in the infrainguinal bypass graft. Did the 
authors make such pressure measurements after establish- 
ing flow in the bypass graft? 
My second comment is that with such measurements 
and C-arm fluoroscopy in the operating room, it is possible 
to localize and treat hese unrecognized inflow stenoses at 
the time of the inftainguinal bypass procedure. Hopefully, 
this will decrease the incidence of failure as a result of 
inflow lesions. Do the authors agree with this? 
Finally, do the authors believe that many of their in- 
flow operations will be replaced with stenting procedures 
for iliac disease? And if so, do they think this will decrease 
or increase the number of failures caused by inflow prob- 
lems? I worry that it will increase these problems. 
Dr. Matthew J. Eagleton. Thank you, Dr. Veith. We 
certainly would agree that some hemodynamically signifi- 
cant inflow stenoses can be missed unless femoral artery 
pressure measurements are obtained after flow has been 
established by the infrainguinal bypass graft. We frequently 
measure femoral artery pressures after completion of the 
infrainguinal bypass, but this is not done on a routine basis. 
When these inflow lesions are identified during the 
operation, we correct these lesions at the time of the 
infrainguinal bypass procedure. In fact, 61% of the inflow 
procedures performed on saphenous vein grafts and 81% of 
those performed on prosthetic grafts were done at the time 
of the infrainguinal bypass procedure. In several cases, the 
need for an inflow procedure was not apparent until after 
the infrainguinal bypass procedure had been performed. 
In this series, 15% of the inflow procedures performed 
were iliac artery balloon angioplasty, and fewer than half of 
these had stents placed. I think that we will see an increase 
in the number of stenting procedures performed to treat 
iliac artery inflow disease. I am not sure whether the use of 
more stenting procedures will result in further inflow prob- 
lems. From the data presented here, the number of patients 
who underwent a stenting procedure was too small to 
make an adequate analysis. 
Dr. Keith D. Calligaro (Philadelphia~ Pa.). Currently, 
I think the position most vascular surgeons ~take is not to 
perform routine surveillance of prosthetic grafts. However, 
we find it helpful and useful to perform routine duplex 
ultrasound scans for prosthetic grafts as we do for vein 
grafts. We would agree with one of your conclusions, that 
prosthetic grafts possibly should be entered into the same 
type of a protocol. And I rise to echo what Dr. Veith said, 
that this may be a worthwhile intervention. When we did 
it, we found that many of the lesions were at the anastomo- 
sis, which could be repaired with a patch or jump graft. If  
there were low velocities throughout the graf L we would 
then get an arteriogram to identify inflow and outflow 
lesions. 
Dr. Eagleton. We agree with your comments. Our 
analysis hows that in prosthetic grafts infloW failure and 
stenoses at the anastomotic sites account for a large per- 
centage of our graft failures. By using routine surveillance, 
these lesions may be detected and corrected, as you have 
stated. We plan to change the way we currently evaluate 
our patients with prosthetic grafts, surveying them on a 
more frequent and routine basis. 
Dr. Enrico Ascher (Brooklyn, N.Y.). I rise to congrat- 
ulate you on your very nicely presented paper. I, however, 
disagree with the recommendation f doing more PTFE 
surveillance on a routine basis. We have done this for 4 
years, and we have been disappointed because we have not 
found any specific parameter that can help us define or 
differentiate he failing from the nonfailing raft. We have 
had grafts that had less than 40 cm/sec of velocity that are 
widely patent for more than 4 years. We have had other 
ones that had excellent flow velocities with no lesions that 
failed all of a sudden. I am disappointed, unfortunately, to
say that in our hands the graft surveillance for PTFE has 
not been rewarding. However, when we pick up those 
grafts when they're failing, then the results are excellent, as 
Dr. Veith said. We had an 82% patency rate at 3.5 years 
when we picked up a failing PTFE graft. But unfortunately, 
we're not able to pick those up in more than 20% of our 
cases.  
Dr. Eagleton. What we would recommend may go 
beyond just surveying the graft itself, but actually perform- 
ing routine patient surveillance. Many of our infrainguinal 
bypass graft failures were a result of failure in the inflow 
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tract. This accounted for a large percentage of our pros- 
thetic graft failures and occurred at a high frequency in 
patients with known multisegmental disease. By surveying 
these patients' aortoiliac system we may detect disease 
progression and intervene before failure. The recent litera- 
ture on using duplex ultrasound to evaluate the aortoiliac 
system ~uggests that we are improving in our ability to 
adequately identify and grade stenoses in this region. This 
method may prove useful for routine patient surveillance 
after infrainguinal bypass procedures. 
Dr. Carl E. Bredenberg (Portland, Me.). When per- 
cutaneous transluminal ngioplasty (PTA) first came out 
and was advocated as an inflow procedure before a distal 
reconstruction, some of us were concerned that its durabil- 
ity, while acceptable as an isolated procedure, might not be 
sufficient to base a distal reconstruction . With return of 
symptoms after an isolated PTA procedure, one could 
always redo the PTA. We were concerned that PTA was 
somewhat less durable than surgical reconsn-uction and 
that failure of PTA in the presence of a distal reconstruc- 
tion would compromise the patency of that distal recon- 
struction. We therefore at that time had a certain reluc- 
tance to use PTA to open an inflow artery that was going to 
supply a distal bypass graft. Because you have emphasized 
in your presentation how important recurrent or progres- 
sive inflow disease is as a cause of failure of infrainguinal 
reconstructions, can you give us any insights as to whether 
we should continue to use PTA for a proximal iliac lesion 
when we are also planning a distal reconstruction, or 
should we be more aggressive at surgical reconstruction f
the aortoiliac disease if we are planning also to perform an 
infrainguinal reconstruction? 
Dr. Eagleton. I believe that we would be fairly aggres- 
sive about performing redo angioplasty on a recurrent 
lesion. The second angioplasty procedure may be aug- 
mented by the placement of a stent. We base our decision 
to perform a more aggressive surgical procedure on where 
the lesion is located, the extent of the lesion, the presence 
ofmultifocal lesions, and the concern for the patency of the 
infrainguinal bypass graft. 
We were not able to statistically show any difference in 
the infrainguinal bypass patency rates in those patients who 
underwent PTA compared with those who underwent an 
aortoiliofemoral bypass procedure or an iliofemoral endar- 
terectomy. The number of patients in each of these groups 
was too small to make an adequate comparison. 
Dr. Kumar  R. Patel (Glen Ridge, N.J.). We are very 
particular about surveillance of our vein grafts, as well. But 
the one question we have not been able to answer to our 
satisfaction is, when you see a vein graft 6 months later and 
there is an increase in the peak systolic velocity, what 
velocity is significant? You mentioned 150 cm/sec. We 
have watched some patients who had velocities of 250 
cm/sec, 300 cm/sec, and we don't  know the answer. Can 
you tell us your basis for picldng 150 cm/sec? 
Dr. Eagleton. The criteria to which we apply signifi- 
cance in surveying our infrainguinal bypass grafts is based 
on studies previously published by Dr. Green and our 
group. The decision to perform a graft revision is rarely 
made only on the peak systolic velocity. Instead, we use a 
combination of recurrent clinical symptoms, a change in 
ankle-brachial index, and the peak systolic velocities. 
Dr. Patel. I 'm sure you have seen some patients who 
have just the increased frequency, with no symptoms and a 
normal ABI. We have seen some patients like that. What 
would you do? Would you go to angiography, or would 
you just continue to watch? 
Dr. Eagleton. We would observe those patients for 
recurrent symptoms, changes in ABI, or further increases 
in the peak systolic frequencies. 
Dr. Robert  P. Leather (Albany, N.Y.). I have one 
question or clarification. It has been our experience that 
inflow occlusion does not necessarily result in the failure of 
an infraingninal vein bypass graft, particularly if it has 
access to collateral flow. Invariably, those bypass grafts 
survive that event. Now, it sounds like you've arbitrarily 
classified the vein bypass graft as a failure if there was inflow 
occlusion; is that correct? 
Dr. Eagleton. The vein grafts were only classified as 
failures if they met our criteria for failure, such as recurrent 
clinical symptoms, changes in ankle-brachial index, and 
altered peak systolic velocities, but not on the patency of 
the inflow. As you observed, there were instances in which 
the inflow failed but the infrainguinal bypasses remained 
patent. Whether these grafts will eventually fail, I am not 
certain. 
Dr. Leather. This is obviously in contrast o inflow 
failure above a synthetic graft, in which it is more than 
likely to result in failure. 
I would also like to reemphasize the importance of the 
pressure after the bypass graft is placed. With the increase 
in flow, a stenotic area that was not critical before then 
becomes critical, and the resting flow rates, even with the 
use of vasodilators, are so low that the degree of stenosis 
has to be >70% diameter to show up on a pressure mea- 
surement. 
Dr. Eagleton. Again, we use intraarterial pressure 
measurements after infrainguinal bypass procedures fre- 
quently, but not on a routine basis. 
Dr. Richard M. Green. I just wanted to make a 
comment and address Dr. Ascher's comment, which we 
would agree with. We have had the chance to follow-up in 
a different study 250 patients who underwent above-lmee 
femoropopliteal bypass grafting with a prosthesis and to 
look at the behavior of these grafts with duplex scanning. 
There is no question that graft velocities in these grafts 
range from 30 to 150 cm/sec, and there is no predictive 
value to the graft velocity. So Dr. Ascher, I agree with you 
100%. But what we're trying to say here is that there are 
other causes of graft failure and that those are things that 
perhaps duplex scanning can pick up. So I don't  think 
we're in any disagreement here. I think the rules are going 
to be different with vein grafts than prosthetic grafts. 
